Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
Anika Therapeutics (NASDAQ: ANIK), a global joint preservation company focusing on early intervention orthopedics, has announced that its President and CEO, Dr. Cheryl Blanchard, will be presenting at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego.
The presentation is scheduled for Monday, March 10, 2025, at 2:30 PM PT / 5:30 PM ET. In addition to the presentation, Anika's management team will be participating in one-on-one investor meetings throughout the event.
Interested parties can access a live webcast of the presentation on the Events and Webcasts page under the Investors section of Anika's website. The presentation will remain archived on the site for 30 days afterward. Investors seeking to schedule meetings with Anika's senior management during the conference can contact the company's Investor Relations department at investorrelations@anika.com.
Anika Therapeutics (NASDAQ: ANIK), un'azienda globale specializzata nella preservazione delle articolazioni e focalizzata sull'intervento precoce in ortopedia, ha annunciato che il suo Presidente e CEO, Dr. Cheryl Blanchard, presenterà al Canaccord Genuity 2025 Musculoskeletal Conference a San Diego.
La presentazione è programmata per lunedì 10 marzo 2025, alle 14:30 PT / 17:30 ET. Oltre alla presentazione, il team di gestione di Anika parteciperà a incontri individuali con gli investitori durante l'evento.
Le parti interessate possono accedere a una diretta streaming della presentazione nella pagina Eventi e Webcast nella sezione Investitori del sito web di Anika. La presentazione rimarrà archiviata sul sito per 30 giorni dopo. Gli investitori che desiderano programmare incontri con il senior management di Anika durante la conferenza possono contattare il dipartimento di Relazioni con gli Investitori dell'azienda all'indirizzo investorrelations@anika.com.
Anika Therapeutics (NASDAQ: ANIK), una empresa global dedicada a la preservación de las articulaciones y enfocada en la intervención temprana en ortopedia, ha anunciado que su Presidenta y CEO, la Dra. Cheryl Blanchard, presentará en la Canaccord Genuity 2025 Musculoskeletal Conference en San Diego.
La presentación está programada para el lunes 10 de marzo de 2025, a las 2:30 PM PT / 5:30 PM ET. Además de la presentación, el equipo de gestión de Anika participará en reuniones uno a uno con inversores durante el evento.
Las partes interesadas pueden acceder a una transmisión en vivo de la presentación en la página de Eventos y Webcasts en la sección de Inversores del sitio web de Anika. La presentación permanecerá archivada en el sitio durante 30 días después. Los inversores que deseen programar reuniones con la alta dirección de Anika durante la conferencia pueden contactar al departamento de Relaciones con Inversores de la empresa en investorrelations@anika.com.
아니카 테라퓨틱스 (NASDAQ: ANIK), 조기 개입 정형외과에 중점을 둔 글로벌 관절 보존 회사는, 사장 겸 CEO인 Cheryl Blanchard 박사가 샌디에이고에서 열리는 Canaccord Genuity 2025 Musculoskeletal Conference에서 발표할 것이라고 발표했습니다.
발표는 2025년 3월 10일 월요일 오후 2:30 PT / 오후 5:30 ET로 예정되어 있습니다. 발표 외에도 아니카의 경영진은 행사 기간 동안 개별 투자자 회의에 참여할 예정입니다.
관심 있는 분들은 아니카 웹사이트의 투자자 섹션 아래 이벤트 및 웹캐스트 페이지에서 발표의 실시간 웹캐스트를 시청할 수 있습니다. 발표는 이후 30일 동안 사이트에 보관됩니다. 회의 중 아니카의 고위 경영진과의 미팅을 예약하고자 하는 투자자는 회사의 투자자 관계 부서에 investorrelations@anika.com으로 연락할 수 있습니다.
Anika Therapeutics (NASDAQ: ANIK), une entreprise mondiale spécialisée dans la préservation des articulations et axée sur l'intervention précoce en orthopédie, a annoncé que sa Présidente et CEO, Dr. Cheryl Blanchard, fera une présentation à la Canaccord Genuity 2025 Musculoskeletal Conference à San Diego.
La présentation est prévue pour le lundi 10 mars 2025, à 14h30 PT / 17h30 ET. En plus de la présentation, l'équipe de direction d'Anika participera à des réunions individuelles avec les investisseurs tout au long de l'événement.
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation sur la page Événements et Webcasts dans la section Investisseurs du site web d'Anika. La présentation restera archivée sur le site pendant 30 jours après. Les investisseurs souhaitant planifier des réunions avec la direction d'Anika pendant la conférence peuvent contacter le département des Relations avec les Investisseurs de l'entreprise à l'adresse investorrelations@anika.com.
Anika Therapeutics (NASDAQ: ANIK), ein globales Unternehmen zur Erhaltung von Gelenken mit Schwerpunkt auf frühzeitiger Intervention in der Orthopädie, hat bekannt gegeben, dass ihre Präsidentin und CEO, Dr. Cheryl Blanchard, auf der Canaccord Genuity 2025 Musculoskeletal Conference in San Diego präsentieren wird.
Die Präsentation ist für Montag, den 10. März 2025, um 14:30 Uhr PT / 17:30 Uhr ET angesetzt. Neben der Präsentation wird das Management-Team von Anika an eins-zu-eins-Investorenmeetings während der Veranstaltung teilnehmen.
Interessierte Parteien können die Live-Übertragung der Präsentation auf der Seite für Veranstaltungen und Webcasts im Bereich Investoren der Anika-Website abrufen. Die Präsentation wird anschließend 30 Tage lang auf der Website archiviert. Investoren, die während der Konferenz Meetings mit dem Senior Management von Anika planen möchten, können die Abteilung für Investor Relations unter investorrelations@anika.com kontaktieren.
- Anika's participation in the Canaccord Genuity Conference demonstrates their active engagement with the investment community
- The company's focus on joint preservation and early intervention orthopedics positions them in a growing healthcare segment
- Management's availability for one-on-one meetings suggests openness to investor communication
- The press release doesn't provide specific information about Anika's financial performance or business updates
- No details about the content of the upcoming presentation were shared
- Investors may need to wait until the conference to learn about any new company developments
BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and CEO of Anika, will present at the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego on Monday, March 10, 2025 at 2:30pm PT / 5:30pm ET. Management will also participate in one-on-one investor meetings throughout the event.
The presentation will be webcast live on the Events and Webcasts page under the Investors section of Anika Therapeutics’ website and will be archived for 30 days following the presentation. For more information about this event or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at investorrelations@anika.com.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
When will Anika Therapeutics (ANIK) present at the Canaccord Genuity 2025 Musculoskeletal Conference?
How can investors watch Anika's (ANIK) presentation at the Canaccord Genuity Conference?
Will Anika Therapeutics (ANIK) management be available for investor meetings at the Canaccord Conference?
What is Anika Therapeutics' (ANIK) business focus according to their March 2025 conference announcement?
Who will represent Anika Therapeutics (ANIK) at the Canaccord Genuity 2025 Musculoskeletal Conference?
